Articles from TheNewswire.com

RADNOR, PA - January 18, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Micron Technology, Inc. (“Micron”) (NASDAQMU) on behalf of those who purchased or otherwise acquired Micron common stock between September 28, 2023, and December 18, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is March 10, 2025.

RADNOR, PA - January 18, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Nextracker Inc. (“Nextracker”) (NASDAQNXT) on behalf of those who purchased or otherwise acquired Nextracker common stock between February 1, 2024, and August 1, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 25, 2025.

RADNOR, PA - January 18, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against MGP Ingredients, Inc. (“MGPI”) (NASDAQMGPI) on behalf of those who purchased or otherwise acquired MGPI common stock between May 4, 2023, and October 30, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 14, 2025.

Brunell Brings 20+ Years of FMCG Expertise to Accelerate Brand Growth and Innovation in Health and Wellness

Innovative Financial Products and Operational Efficiency Driving Business Expansion

Represents a Key Step Toward Validating Gedeptin Potential in Solid Tumor Therapy

RADNOR, PA - January 18, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Celsius Holdings, Inc. (“Celsius”) (NASDAQCELH) on behalf of those who purchased or otherwise acquired Celsius common stock between February 29, 2024, and September 4, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is January 21, 2025.

RADNOR, PA - January 18, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Zeta Global Holdings Corp. (“Zeta”) (NYSEZETA) on behalf of those who purchased or otherwise acquired Zeta securities between February 27, 2024, and November 13, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is January 21, 2025.

RADNOR, PA - January 18, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava”) (NASDAQSAVA) on behalf of those who purchased or otherwise acquired Cassava securities between February 7, 2024, and November 24, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 10, 2025.

HOUSTON, TEXAS - January 14, 2025 (NEWMEDIAWIRE) -

Licensing Fees From AiBtl and Strategic Partners Now Total $696,000, Bolstering Confidence in AiBtl’s Plans

RADNOR, PA - January 18, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics”) (NASDAQAPLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 18, 2025.

RADNOR, PA - January 18, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against Enphase Energy, Inc. (NASDAQENPH) (“Enphase” or the “Company”) on behalf of all persons and entities who purchased or otherwise acquired Enphase common stock between April 25, 2023, and October 22, 2024, inclusive (the “Class Period”).  This action, captioned The Trustees of the Welfare and Pension Funds of Local 464A - Pension Fund v. Enphase Energy, Inc., et al., Case No. 3:24-cv-09038, was filed in the United States District Court for the Northern District of California.

RADNOR, PA - January 18, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Kyverna Therapeutics, Inc. (“Kyverna”) (NASDAQKYTX) on behalf of those who purchased Kyverna common stock pursuant and/or traceable to Kyverna’s February 8, 2024 initial public offering (”IPO”). The lead plaintiff deadline is February 7, 2025.

RADNOR, PA - January 18, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that securities class action lawsuits have been filed against DENTSPLY SIRONA Inc. (“DENTSPLY”) (NASDAQXRAY) on behalf of those who purchased or otherwise acquired DENTSPLY common stock between May 6, 2021, and November 6, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is January 27, 2025.

RADNOR, PA - January 18, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Symbotic Inc. (“Symbotic”) (NASDAQSYM) on behalf of those who purchased or otherwise acquired Symbotic securities between February 8, 2024, and November 26, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 3, 2025.

RADNOR, PA - January 18, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that securities class action lawsuits have been filed in the United States District Court for the Northern District of California against Marqeta, Inc. (“Marqeta”) (NASDAQMQ) on behalf of those who purchased or otherwise acquired Marqeta securities between May 7, 2024, and November 4, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 7, 2025.

BROOMFIELD, CO - January 17, 2025 (NEWMEDIAWIRE) - Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced the closing of an underwritten public offering of 100,000 shares of common stock and 143,900,000 pre-funded warrants with each share of common stock and each pre-funded warrant accompanied by (i) a series A common warrant to purchase one (1) common share at an exercise price of $0.20 per share and (ii) a series B common warrant to purchase one (1) common share at an exercise price of $0.20 per share. The combined public offering price of each share of common stock together with the accompanying series A and series B common warrants is $0.10, and the combined public offering price of each pre-funded warrant together with the accompanying series A and series B common warrants is $0.09999. In addition, the Company granted to the underwriter a 45 day option to purchase up to an additional 21,000,000 shares of its common stock (or pre-funded warrants), at the public offering price, less underwriting discounts and commissions, and up to an additional 21,000,000 series A common warrants and up to an additional 21,000,000 series B common warrants at a nominal price to cover over-allotment sales. The underwriter exercised its option to purchase 21,000,000 series A common warrants and 21,000,000 series B common warrants. All shares of common stock, pre-funded warrants, series A common warrants and series B common warrant were sold by Aclarion. The closing of the public offering occurred on January 16, 2025.

RADNOR, PA - January 17, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge”) (NASDAQBIOA) on behalf of those who purchased stock pursuant and/or traceable to BioAge's registration statement for its initial public offering (“IPO”) held on or about September 26, 2024 (the “Class Period”). The lead plaintiff deadline is March 10, 2025.

NEW YORK - January 17, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQAPLT) on behalf of investors that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024 (the “Class Period”).

RADNOR, PA - January 16, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Micron Technology, Inc. (“Micron”) (NASDAQMU) on behalf of those who purchased or otherwise acquired Micron common stock between September 28, 2023, and December 18, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is March 10, 2025.

RADNOR, PA - January 16, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Zeta Global Holdings Corp. (“Zeta”) (NYSEZETA) on behalf of those who purchased or otherwise acquired Zeta securities between February 27, 2024, and November 13, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is January 21, 2025.

RADNOR, PA - January 16, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against Enphase Energy, Inc. (NASDAQENPH) (“Enphase” or the “Company”) on behalf of all persons and entities who purchased or otherwise acquired Enphase common stock between April 25, 2023, and October 22, 2024, inclusive (the “Class Period”).  This action, captioned The Trustees of the Welfare and Pension Funds of Local 464A - Pension Fund v. Enphase Energy, Inc., et al., Case No. 3:24-cv-09038, was filed in the United States District Court for the Northern District of California.

RADNOR, PA - January 16, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Celsius Holdings, Inc. (“Celsius”) (NASDAQCELH) on behalf of those who purchased or otherwise acquired Celsius common stock between February 29, 2024, and September 4, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is January 21, 2025.

RADNOR, PA - January 16, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Nextracker Inc. (“Nextracker”) (NASDAQNXT) on behalf of those who purchased or otherwise acquired Nextracker common stock between February 1, 2024, and August 1, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 25, 2025.

RADNOR, PA - January 16, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that securities class action lawsuits have been filed against DENTSPLY SIRONA Inc. (“DENTSPLY”) (NASDAQXRAY) on behalf of those who purchased or otherwise acquired DENTSPLY common stock between May 6, 2021, and November 6, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is January 27, 2025.

RADNOR, PA - January 16, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava”) (NASDAQSAVA) on behalf of those who purchased or otherwise acquired Cassava securities between February 7, 2024, and November 24, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 10, 2025.

NEW YORK - January 16, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQAPLT) on behalf of investors that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024 (the “Class Period”).

RADNOR, PA - January 16, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that securities class action lawsuits have been filed in the United States District Court for the Northern District of California against Marqeta, Inc. (“Marqeta”) (NASDAQMQ) on behalf of those who purchased or otherwise acquired Marqeta securities between May 7, 2024, and November 4, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 7, 2025.

RADNOR, PA - January 16, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics”) (NASDAQAPLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 18, 2025.

RADNOR, PA - January 16, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Symbotic Inc. (“Symbotic”) (NASDAQSYM) on behalf of those who purchased or otherwise acquired Symbotic securities between February 8, 2024, and November 26, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 3, 2025.

RADNOR, PA - January 16, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Kyverna Therapeutics, Inc. (“Kyverna”) (NASDAQKYTX) on behalf of those who purchased Kyverna common stock pursuant and/or traceable to Kyverna’s February 8, 2024 initial public offering (”IPO”). The lead plaintiff deadline is February 7, 2025.

RADNOR, PA - January 16, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Wolfspeed, Inc. (“Wolfspeed”) (NYSEWOLF) on behalf of those who purchased or otherwise acquired Wolfspeed securities between August 16, 2023, and November 6, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is January 17, 2025.

Company Showcases Strong Operational Execution, Revenue, and Cash Flow Growth With Expectations of Multiple Liquidity and Enhanced Return Events During 2025, Bolstering Capital Available for New Investments

Focusing on Neuroscience, Oncology, and Ophthalmology Pipelines

LAS VEGAS - January 16, 2025 (NEWMEDIAWIRE) - Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced that Ainnova has started the process of implementing the 4 advanced AI-driven algorithms the company acquired last month into its state-of-the-art Vision AI platform. 

DUBAI, UAE - January 16, 2025 (NEWMEDIAWIRE) - Blackwell 3D Construction Corp. (OTC: BDCC) (“Blackwell 3D” or the “Company”), an innovative 3D house printing technology company, is pleased to announce that it has entered into an agreement with Mr. Narshimulu Madugula, a prominent landowner near Hyderabad, India, to develop a 25-villa residential project using cutting-edge 3D construction techniques. This collaboration aims to bring sustainable, cost-effective, and innovative housing solutions to the region.

Noochies! has secured initial orders from distributors in Singapore, Europe, and Canada

RADNOR, PA - January 15, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Signet Jewelers Limited (NYSESIG) (“Signet”).

(NewMediaWire) - January 15, 2025 - Glendale, CA – On January 18, 2025, esteemed military aerospace historian Michael Schratt will deliver a compelling and fully illustrated PowerPoint lecture titled "Retrievals of the Third Kind." This landmark presentation will delve into the highly classified operations surrounding UFO crash retrievals, which have long eluded Congressional oversight and public scrutiny. Recent hearings in Washington D.C. have shed light on the existence of ongoing government programs focused on recovering extraterrestrial craft and biological entities. In this enlightening lecture, Schratt will draw from extensive research and firsthand accounts to explore these clandestine operations that have shaped an important part of our national history. Michael Schratt will provide compelling references to firsthand military witnesses who have encountered extraterrestrial hardware and "biologics." These accounts, meticulously compiled by prominent UFO researcher Leonard Stringfield, offer a unique perspective into the realities of UFO recovery efforts. Attendees can expect a visually captivating experience, featuring refined pencil drawings and full-color 3D renderings based on eyewitness testimonies of UFO recoveries. Key topics will include: • The UFO stored at Wright Field in 1946 • Encounters with extraterrestrial craft and bodies at Wright Field during 1946 • Accounts from a U.S. Marine who guarded a 40-foot disc in 1963 This presentation is not only an exploration of the unknown but also an urgent discussion on the implications of government secrecy in the realm of extraterrestrial phenomena. Michael Schratt invites all interested parties to join him in uncovering these riveting truths about UFO crash retrievals and their potential impact on our understanding of human history.| Event Details: Date: January 18, 2025 at the Martial Arts History Museum 201 North Brand Blvd., B100 Glendale CA91203. Cost is $20 for Adults, $5 for kids. Time: 4:00 PM to 7:00 PM For more information about the event or to schedule an interview with Michael Schratt, please contact Jeff Powell at (310) 402-8353. Join us as we take a deep dive.

RADNOR, PA - January 15, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of TransMedics Group, Inc. (NASDAQTMDX) (“TransMedics”).

RADNOR, PA - January 15, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge”) (NASDAQBIOA) on behalf of those who purchased stock pursuant and/or traceable to BioAge's registration statement for its initial public offering (“IPO”) held on or about September 26, 2024 (the “Class Period”). The lead plaintiff deadline is March 10, 2025.

NEW YORK - January 15, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQTMDX).

CHEYENNE, WY - January 15, 2025 (NEWMEDIAWIRE) - Paragon Square Inc. (the Company) announces acquisition of a multimillion dollar real estate portfolio and the launch of the Regulation CF offering filed with the SEC.

RADNOR, PA - January 15, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against MGP Ingredients, Inc. (“MGPI”) (NASDAQMGPI) on behalf of those who purchased or otherwise acquired MGPI common stock between May 4, 2023, and October 30, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 14, 2025.

NEW YORK - January 15, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQAPLT) on behalf of investors that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024 (the “Class Period”).

LOS ANGELES - January 15, 2025 (NEWMEDIAWIRE) - US Nuclear Corp. (OTC: UCLE), is pleased to announce they have developed a device called the “Gauntlet Sentry,” designed specifically to protect border crossings, government buildings and military installations, from vehicles or terrorists transporting explosive devices emitting nuclear radiation, fumes from explosives or hazardous substances, including fentanyl.

BROOMFIELD, CO - January 15, 2025 (NEWMEDIAWIRE) - Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced the pricing of an underwritten public offering of approximately 144,000,000 shares of common stock (or pre-funded warrants in lieu thereof) with each share of common stock (or pre-funded warrant) accompanied by (i) a series A common warrant to purchase one (1) common share at an exercise price of $0.20 per share and (ii) a series B common warrant to purchase one (1) common share at an exercise price of $0.20 per share. The combined public offering price of each share of common stock together with the accompanying series A and series B common warrants is $0.10, and the combined public offering price of each pre-funded warrant together with the accompanying series A and series B common warrants is $0.09999. The Company also granted the underwriter a 45 day option to purchase up to 21,000,000 additional shares of common stock (or pre-funded warrants), up to 21,000,000 series A common warrants and up to 21,000,000 series B common warrants, to cover over-allotments.  The closing of the public offering is expected to occur on or about January 16, 2025, subject to the satisfaction of customary closing conditions.

FREMONT, CA - January 15, 2025 (NEWMEDIAWIRE) - ABVC BioPharma, Inc. (NASDAQABVC), a clinical-stage biopharmaceutical company focused on innovative treatments in ophthalmology, CNS (central nervous system), and oncology/hematology, is proud to announce the advancements in its innovative treatments for Major Depressive Disorder (MDD) and Attention-Deficit/Hyperactivity Disorder (ADHD), highlighting the promising results achieved through rigorous clinical research and development.

RADNOR, PA - January 14, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Wolfspeed, Inc. (“Wolfspeed”) (NYSEWOLF) on behalf of those who purchased or otherwise acquired Wolfspeed securities between August 16, 2023, and November 6, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is January 17, 2025.

RADNOR, PA - January 14, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Nextracker Inc. (“Nextracker”) (NASDAQNXT) on behalf of those who purchased or otherwise acquired Nextracker common stock between February 1, 2024, and August 1, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 25, 2025.

RADNOR, PA - January 14, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Symbotic Inc. (“Symbotic”) (NASDAQSYM) on behalf of those who purchased or otherwise acquired Symbotic securities between February 8, 2024, and November 26, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 3, 2025.

RADNOR, PA - January 14, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Celsius Holdings, Inc. (“Celsius”) (NASDAQCELH) on behalf of those who purchased or otherwise acquired Celsius common stock between February 29, 2024, and September 4, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is January 21, 2025.

RADNOR, PA - January 14, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that securities class action lawsuits have been filed against DENTSPLY SIRONA Inc. (“DENTSPLY”) (NASDAQXRAY) on behalf of those who purchased or otherwise acquired DENTSPLY common stock between May 6, 2021, and November 6, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is January 27, 2025.

RADNOR, PA - January 14, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Kyverna Therapeutics, Inc. (“Kyverna”) (NASDAQKYTX) on behalf of those who purchased Kyverna common stock pursuant and/or traceable to Kyverna’s February 8, 2024 initial public offering (”IPO”). The lead plaintiff deadline is February 7, 2025.

Vancouver, British Columbia, January 14th, 2025, - TheNewswire - Rockland Resources Ltd. (the “Company” or "Rockland") (CSE: RKL), is pleased to announce that, further to its news release dated January 7, 2024, it has settled an aggregate of $172,500 of debt (the “Debt”) owed to various creditors (the “Creditors”). In settlement of the Debt, the Company issued 3,450,000 Units at a deemed price of $0.05 per Unit. Each unit consists of one common share and one half of one common share purchase warrant. Each whole warrant entitles the holder to purchase one additional common share (a “Warrant Share”) of the Company at a price of   $0.10 per warrant share for a period of 24 months.

RADNOR, PA - January 14, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against Enphase Energy, Inc. (NASDAQENPH) (“Enphase” or the “Company”) on behalf of all persons and entities who purchased or otherwise acquired Enphase common stock between April 25, 2023, and October 22, 2024, inclusive (the “Class Period”). This action, captioned The Trustees of the Welfare and Pension Funds of Local 464A - Pension Fund v. Enphase Energy, Inc., et al., Case No. 3:24-cv-09038, was filed in the United States District Court for the Northern District of California.

RADNOR, PA - January 14, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava”) (NASDAQSAVA) on behalf of those who purchased or otherwise acquired Cassava securities between February 7, 2024, and November 24, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 10, 2025.

RADNOR, PA - January 14, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that securities class action lawsuits have been filed in the United States District Court for the Northern District of California against Marqeta, Inc. (“Marqeta”) (NASDAQMQ) on behalf of those who purchased or otherwise acquired Marqeta securities between May 7, 2024, and November 4, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 7, 2025.

RADNOR, PA - January 14, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics”) (NASDAQAPLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 18, 2025.

NEW YORK - January 14, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQAZN) on behalf of investors that purchased or otherwise acquired AstraZeneca securities, including the Company’s American Depositary Shares (“ADSs”), between February 23, 2022 and December 17, 2024 (the “Class Period”).

NEW YORK - January 14, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQTMDX).

NEW YORK - January 14, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQAPLT) on behalf of investors that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024 (the “Class Period”).

RADNOR, PA - January 14, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Zeta Global Holdings Corp. (“Zeta”) (NYSEZETA) on behalf of those who purchased or otherwise acquired Zeta securities between February 27, 2024, and November 13, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is January 21, 2025.

Nakhooda Brings Over 25 Years of Financial, Commercial and Operational Experience With Rapidly Growing Companies, Including Amazon

NEW YORK - January 14, 2025 (NEWMEDIAWIRE) - Raadr, Inc., now doing business as Telvantis (OTC PINK: RDAR) ("Telvantis" or the "Company"), today announced significant progress in its transformation into a global telecommunications company. Through the strategic acquisition of Mexedia SpA's U.S. and Ireland operating units and a comprehensive restructuring, Telvantis is positioned to deliver innovative solutions and redefine its role in the telecom industry.

Vancouver B.C. - TheNewswire - January 14, 2025 – TERRA CLEAN ENERGY CORP. (“Terra” or the “Company”) (CSE: TCEC, OTCQB: TCEFF, FSE: C9O0, announced that, at the request of the Company, Manning Elliott LLP, Chartered Professional Accountants (the "Former Auditor") has resigned as auditor of the Company, and that Crowe MacKay LLP, Chartered Accountants (the "Successor Auditor") has been appointed as the Company's Successor Auditor.

RADNOR, PA - January 13, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against MGP Ingredients, Inc. (“MGPI”) (NASDAQMGPI) on behalf of those who purchased or otherwise acquired MGPI common stock between May 4, 2023, and October 30, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 14, 2025.

NEW YORK - January 13, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQAPLT) on behalf of investors that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024 (the “Class Period”).

NEW YORK - January 13, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Nextracker Inc. (“Nextracker” or the “Company”) (NASDAQNXT) on behalf of investors that purchased or otherwise acquired Nextracker securities between February 1, 2024 and August 1, 2024 (the “Class Period”).

NEW YORK - January 13, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQRVNC) on behalf of investors that purchased or otherwise acquired Revance securities between February 29, 2024 and December 6, 2024 (the “Class Period”).

NEW YORK - January 13, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQAZN) on behalf of investors that purchased or otherwise acquired AstraZeneca securities, including the Company’s American Depositary Shares (“ADSs”), between February 23, 2022 and December 17, 2024 (the “Class Period”).

Rouyn Noranda, Q.C. – TheNewswire - January 13, 2025 - Granada Gold Mine Inc. (TSXV: GGM) (OTC: GBBFF) (Frankfurt: B6D) (the "Company" or "Granada") is pleased to report that it has engaged the services of Goldminds Geoservices to complete the required revision to its restauration plan at Granada Gold Mine.  This revision is required every 5 years to account for changes in any activities on site that may affect the terrain as well as the costs or modifications to proposed activities.  

NEW YORK - January 13, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQTMDX).

Advancements Position GEO-CM04S1 as a Leading Vaccine Candidate Addressing Unmet Medical Needs, Especially Among Immunocompromised Patients